{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:48:51Z","timestamp":1772232531575,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metab"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kaposi sarcoma (KS) is a neoplastic disease etiologically associated with infection by the Kaposi sarcoma-associated herpesvirus (KSHV). KS manifests primarily as cutaneous lesions in individuals due to either age (classical KS), HIV infection (epidemic KS), or tissue rejection preventatives in transplantation (iatrogenic KS) but can also occur in individuals, predominantly in sub-Saharan Africa (SSA), lacking any obvious immune suppression (endemic KS). The high endemicity of KSHV and human immunodeficiency virus-1 (HIV) co-infection in Africa results in KS being one of the top 5 cancers there. As with most viral cancers, infection with KSHV alone is insufficient to induce tumorigenesis. Indeed, KSHV infection of primary human endothelial cell cultures, even at high levels, is rarely associated with long-term culture, transformation, or growth deregulation, yet infection in vivo is sustained for life. Investigations of immune mediators that distinguish KSHV infection, KSHV\/HIV co-infection, and symptomatic KS disease have yet to reveal consistent correlates of protection against or progression to KS. In addition to viral infection, it is plausible that pathogenesis also requires an immunological and metabolic environment permissive to the abnormal endothelial cell growth evident in KS tumors. In this study, we explored whether plasma metabolomes could differentiate asymptomatic KSHV-infected individuals with or without HIV co-infection and symptomatic KS from each other.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To investigate how metabolic changes may correlate with co-infections and tumorigenesis, plasma samples derived from KSHV seropositive sub-Saharan African subjects in three groups, (A) asymptomatic (lacking neoplastic disease) with KSHV infection only, (B) asymptomatic co-infected with KSHV and HIV, and (C) symptomatic with clinically diagnosed KS, were subjected to analysis of lipid and polar metabolite profiles<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Polar and nonpolar plasma metabolic differentials were evident in both comparisons. Integration of the metabolic findings with our previously reported KS transcriptomics data suggests dysregulation of amino acid\/urea cycle and purine metabolic pathways, in concert with viral infection in KS disease progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study is, to our knowledge, the first to report human plasma metabolic differentials between in vivo KSHV infection and co-infection with HIV, as well as differentials between co-infection and epidemic KS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40170-023-00316-0","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T07:02:53Z","timestamp":1693465373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states"],"prefix":"10.1186","volume":"11","author":[{"given":"Sara R.","family":"Privatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Pereira","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salum J.","family":"Lidenge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Ngowi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Ngalamika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Mwaiselage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Adamec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"5192","key":"316_CR1","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma. Science. 1994;266(5192):1865\u20139.","journal-title":"Science"},{"issue":"18","key":"316_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJM199505043321801","volume":"332","author":"PS Moore","year":"1995","unstructured":"Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi\u2019s sarcoma in patients with and those without HIV infection. N Engl J Med. 1995;332(18):1181\u20135.","journal-title":"N Engl J Med"},{"issue":"3","key":"316_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/oxfordjournals.aje.a009440","volume":"147","author":"PS Moore","year":"1998","unstructured":"Moore PS, Chang Y. Kaposi\u2019s sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol. 1998;147(3):217\u201321.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"316_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","volume":"5","author":"E Cesarman","year":"2019","unstructured":"Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nat Rev Dis Primers. 2019;5(1):9.","journal-title":"Nat Rev Dis Primers"},{"key":"316_CR5","doi-asserted-by":"crossref","unstructured":"Grabar S, Costagliola D. Epidemiology of kaposi\u2019s sarcoma. Cancers. 2021;13(22):5692.","DOI":"10.3390\/cancers13225692"},{"issue":"1","key":"316_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25658","volume":"24","author":"JL Castilho","year":"2021","unstructured":"Castilho JL, Kim A, Jenkins CA, Grinsztejn B, Gotuzzo E, Fink V, et al. Antiretroviral therapy and Kaposi\u2019s sarcoma trends and outcomes among adults with HIV in Latin America. J Int AIDS Soc. 2021;24(1): e25658.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"316_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0190-9622(81)80010-2","volume":"5","author":"AE Friedman-Kien","year":"1981","unstructured":"Friedman-Kien AE. Disseminated Kaposi\u2019s sarcoma syndrome in young homosexual men. J Am Acad Dermatol. 1981;5(4):468\u201371.","journal-title":"J Am Acad Dermatol"},{"issue":"8682","key":"316_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0140-6736(90)90041-3","volume":"335","author":"AE Friedman-Kien","year":"1990","unstructured":"Friedman-Kien AE, Saltzman BR, Cao YZ, Nestor MS, Mirabile M, Li JJ, et al. Kaposi\u2019s sarcoma in HIV-negative homosexual men. Lancet. 1990;335(8682):168\u20139.","journal-title":"Lancet"},{"issue":"2","key":"316_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/j.seminoncol.2014.12.029","volume":"42","author":"AE Grulich","year":"2015","unstructured":"Grulich AE, Vajdic CM. The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol. 2015;42(2):247\u201357.","journal-title":"Semin Oncol"},{"issue":"10","key":"316_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri EA, Cesarman E, Boshoff C. Kaposi\u2019s sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010;10(10):707\u201319.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"316_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1200\/JCO.2013.51.6757","volume":"32","author":"M Bower","year":"2014","unstructured":"Bower M, Dalla Pria A, Coyle C, Andrews E, Tittle V, Dhoot S, et al. Prospective stage-stratified approach to AIDS-related Kaposi\u2019s sarcoma. J Clin Oncol. 2014;32(5):409\u201314.","journal-title":"J Clin Oncol"},{"issue":"5","key":"316_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/aid.2020.0099","volume":"37","author":"O Ngalamika","year":"2021","unstructured":"Ngalamika O, Munsaka S, Lidenge SJ, West JT, Wood C. Antiretroviral therapy for HIV-associated cutaneous Kaposi\u2019s sarcoma: clinical, HIV-related, and sociodemographic predictors of outcome. AIDS Res Hum Retroviruses. 2021;37(5):368\u201372.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"316_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006844","volume":"14","author":"FY Tso","year":"2018","unstructured":"Tso FY, Kossenkov AV, Lidenge SJ, Ngalamika O, Ngowi JR, Mwaiselage J, et al. RNA-Seq of Kaposi\u2019s sarcoma reveals alterations in glucose and lipid metabolism. PLoS Pathog. 2018;14(1): e1006844.","journal-title":"PLoS Pathog"},{"issue":"7","key":"316_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008681","volume":"16","author":"SJ Lidenge","year":"2020","unstructured":"Lidenge SJ, Kossenkov AV, Tso FY, Wickramasinghe J, Privatt SR, Ngalamika O, et al. Comparative transcriptome analysis of endemic and epidemic Kaposi\u2019s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis. PLoS Pathog. 2020;16(7): e1008681.","journal-title":"PLoS Pathog"},{"key":"316_CR15","doi-asserted-by":"crossref","unstructured":"Gothland A, Jary A, Grange P, Leducq V, Beauvais-Remigereau L, Dupin N, et al. Harnessing redox disruption to treat human herpesvirus 8 (HHV-8) related malignancies. Antioxidants (Basel). 2022;12(1).","DOI":"10.3390\/antiox12010084"},{"issue":"17","key":"316_CR16","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.18632\/oncotarget.27569","volume":"11","author":"SJ Lidenge","year":"2020","unstructured":"Lidenge SJ, Tso FY, Ngalamika O, Kolape J, Ngowi JR, Mwaiselage J, et al. Lack of CD8(+) T-cell co-localization with Kaposi\u2019s sarcoma-associated herpesvirus infected cells in Kaposi\u2019s sarcoma tumors. Oncotarget. 2020;11(17):1556\u201372.","journal-title":"Oncotarget"},{"issue":"8","key":"316_CR17","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/infdis\/jiy654","volume":"219","author":"SJ Lidenge","year":"2019","unstructured":"Lidenge SJ, Tso FY, Ngalamika O, Ngowi JR, Mortazavi Y, Kwon EH, et al. Similar immunological profiles between African endemic and human immunodeficiency virus type 1-associated epidemic Kaposi sarcoma (KS) patients reveal the primary role of KS-Associated herpesvirus in KS pathogenesis. J Infect Dis. 2019;219(8):1318\u201328.","journal-title":"J Infect Dis"},{"key":"316_CR18","doi-asserted-by":"crossref","unstructured":"Lidenge SJ, Tso FY, Mortazavi Y, Ngowi JR, Shea DM, Mwaiselage J, et al. Viral and immunological analytes are poor predictors of the clinical treatment response in Kaposi\u2019s sarcoma patients. Cancers (Basel). 2020;12(6).","DOI":"10.3390\/cancers12061594"},{"issue":"8","key":"316_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002866","volume":"8","author":"T Delgado","year":"2012","unstructured":"Delgado T, Sanchez EL, Camarda R, Lagunoff M. Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection. PLoS Pathog. 2012;8(8):e1002866.","journal-title":"PLoS Pathog"},{"key":"316_CR20","doi-asserted-by":"crossref","unstructured":"Lagunoff M. Activation of cellular metabolism during latent Kaposi\u2019s sarcoma herpesvirus infection. Curr Opin Virol. 2016;19:45\u20139.","DOI":"10.1016\/j.coviro.2016.06.012"},{"key":"316_CR21","doi-asserted-by":"crossref","unstructured":"Sanchez EL, Pulliam TH, Dimaio TA, Thalhofer AB, Delgado T, Lagunoff M. Glycolysis, glutaminolysis, and fatty acid synthesis are required for distinct stages of Kaposi\u2019s sarcoma-associated herpesvirus lytic replication. J Virol. 2017;91(10).","DOI":"10.1128\/JVI.02237-16"},{"issue":"23","key":"316_CR22","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1073\/pnas.1004882107","volume":"107","author":"T Delgado","year":"2010","unstructured":"Delgado T, Carroll PA, Punjabi AS, Margineantu D, Hockenbery DM, Lagunoff M. Induction of the Warburg effect by Kaposi\u2019s sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc Natl Acad Sci U S A. 2010;107(23):10696\u2013701.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"316_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005052","volume":"11","author":"EL Sanchez","year":"2015","unstructured":"Sanchez EL, Carroll PA, Thalhofer AB, Lagunoff M. Latent KSHV infected endothelial cells are glutamine addicted and require glutaminolysis for survival. PLoS Pathog. 2015;11(7): e1005052.","journal-title":"PLoS Pathog"},{"issue":"10","key":"316_CR24","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1021\/ac3000418","volume":"84","author":"T Pluskal","year":"2012","unstructured":"Pluskal T, Uehara T, Yanagida M. Highly accurate chemical formula prediction tool utilizing high-resolution mass spectra, MS\/MS fragmentation, heuristic rules, and isotope pattern matching. Anal Chem. 2012;84(10):4396\u2013403.","journal-title":"Anal Chem"},{"issue":"1","key":"316_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nmeth.4512","volume":"15","author":"Z Lai","year":"2018","unstructured":"Lai Z, Tsugawa H, Wohlgemuth G, Mehta S, Mueller M, Zheng Y, et al. Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics. Nat Methods. 2018;15(1):53\u20136.","journal-title":"Nat Methods"},{"key":"316_CR26","doi-asserted-by":"publisher","first-page":"38881","DOI":"10.1038\/srep38881","volume":"6","author":"B Li","year":"2016","unstructured":"Li B, Tang J, Yang Q, Cui X, Li S, Chen S, et al. Performance evaluation and online realization of data-driven normalization methods used in LC\/MS based untargeted metabolomics analysis. Sci Rep. 2016;6:38881.","journal-title":"Sci Rep"},{"key":"316_CR27","doi-asserted-by":"crossref","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388-W96.","DOI":"10.1093\/nar\/gkab382"},{"issue":"24","key":"316_CR28","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.1021\/ac9019522","volume":"81","author":"T Kind","year":"2009","unstructured":"Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography\/mass spectrometry. Anal Chem. 2009;81(24):10038\u201348.","journal-title":"Anal Chem"},{"key":"316_CR29","doi-asserted-by":"crossref","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vazquez-Fresno R, et al. HMDB 4.0: the Human Metabolome Database for 2018. Nucleic Acids Res. 2018;46(D1):D608-D17.","DOI":"10.1093\/nar\/gkx1089"},{"key":"316_CR30","doi-asserted-by":"crossref","unstructured":"Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46(W1):W486-W94.","DOI":"10.1093\/nar\/gky310"},{"key":"316_CR31","doi-asserted-by":"crossref","unstructured":"Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Role of cardiolipin in mitochondrial function and dynamics in health and disease: molecular and pharmacological aspects. Cells. 2019;8(7):728.","DOI":"10.3390\/cells8070728"},{"key":"316_CR32","doi-asserted-by":"crossref","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218(1).","DOI":"10.1084\/jem.20201606"},{"key":"316_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","volume":"698","author":"S Noorolyai","year":"2019","unstructured":"Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K\/AKT signalling pathway and cancer. Gene. 2019;698:120\u20138.","journal-title":"Gene"},{"key":"316_CR34","doi-asserted-by":"crossref","unstructured":"Cirone M. Cancer cells dysregulate PI3K\/AKT\/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses. Crit Rev Biochem Mol Biol. 2021;56(5):500\u20139.","DOI":"10.1080\/10409238.2021.1934811"},{"key":"316_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742736","volume":"12","author":"S Olund Villumsen","year":"2021","unstructured":"Olund Villumsen S, Benfeitas R, Knudsen AD, Gelpi M, Hogh J, Thomsen MT, et al. Integrative lipidomics and metabolomics for system-level understanding of the metabolic syndrome in long-term treated HIV-infected individuals. Front Immunol. 2021;12: 742736.","journal-title":"Front Immunol"},{"key":"316_CR36","doi-asserted-by":"crossref","unstructured":"Ali ES, Ben-Sahra I. Regulation of nucleotide metabolism in cancers and immune disorders. Trends Cell Biol. 2023.","DOI":"10.1016\/j.tcb.2023.03.003"},{"issue":"20","key":"316_CR37","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1002\/cncr.30829","volume":"123","author":"Y Long","year":"2017","unstructured":"Long Y, Sanchez-Espiridion B, Lin M, White L, Mishra L, Raju GS, et al. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 2017;123(20):4066\u201374.","journal-title":"Cancer"},{"key":"316_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.725284","volume":"11","author":"F Zhao","year":"2021","unstructured":"Zhao F, An R, Wang L, Shan J, Wang X. Specific gut microbiome and serum metabolome changes in lung cancer patients. Front Cell Infect Microbiol. 2021;11: 725284.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7\u20138","key":"316_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10495-021-01682-0","volume":"26","author":"X Dai","year":"2021","unstructured":"Dai X, Wang D, Zhang J. Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis. 2021;26(7\u20138):385\u2013414.","journal-title":"Apoptosis"},{"key":"316_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2023.200259","volume":"15","author":"O Vladimirova","year":"2023","unstructured":"Vladimirova O, Soldan S, Su C, Kossenkov A, Ngalamika O, Tso FY, et al. Elevated iNOS and 3\u2019-nitrotyrosine in Kaposi\u2019s sarcoma tumors and mouse model. Tumour Virus Res. 2023;15: 200259.","journal-title":"Tumour Virus Res"},{"key":"316_CR41","doi-asserted-by":"crossref","unstructured":"N SNC, Devi A, Sahu S, Alugoju P. Molecular mechanisms of action of trehalose in cancer: a comprehensive review. Life Sci. 2021;269:118968.","DOI":"10.1016\/j.lfs.2020.118968"},{"issue":"1","key":"316_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QAD.0000000000000511","volume":"29","author":"M Somsouk","year":"2015","unstructured":"Somsouk M, Estes JD, Deleage C, Dunham RM, Albright R, Inadomi JM, et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS. 2015;29(1):43\u201351.","journal-title":"AIDS"},{"key":"316_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.589508","volume":"10","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu F, Fan N, Zhou C, Li D, Macvicar T, et al. Targeting glutaminolysis: new perspectives to understand cancer development and novel strategies for potential target therapies. Front Oncol. 2020;10: 589508.","journal-title":"Front Oncol"},{"issue":"7851","key":"316_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645\u201351.","journal-title":"Nature"},{"key":"316_CR45","doi-asserted-by":"crossref","unstructured":"Ariav Y, Ch'ng JH, Christofk HR, Ron-Harel N, Erez A. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response. Sci Adv. 2021;7(21).","DOI":"10.1126\/sciadv.abg6165"},{"issue":"6","key":"316_CR46","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","volume":"162","author":"CH Chang","year":"2015","unstructured":"Chang CH, Qiu J, O\u2019Sullivan D, Buck MD, Noguchi T, Curtis JD, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell. 2015;162(6):1229\u201341.","journal-title":"Cell"},{"issue":"7","key":"316_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002124","volume":"7","author":"L Vastag","year":"2011","unstructured":"Vastag L, Koyuncu E, Grady SL, Shenk TE, Rabinowitz JD. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 2011;7(7): e1002124.","journal-title":"PLoS Pathog"},{"issue":"5","key":"316_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019901","volume":"6","author":"T Lyngdoh","year":"2011","unstructured":"Lyngdoh T, Marques-Vidal P, Paccaud F, Preisig M, Waeber G, Bochud M, et al. Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS ONE. 2011;6(5): e19901.","journal-title":"PLoS ONE"},{"issue":"6","key":"316_CR49","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/ATVBAHA.117.309128","volume":"37","author":"R Spiga","year":"2017","unstructured":"Spiga R, Marini MA, Mancuso E, Di Fatta C, Fuoco A, Perticone F, et al. Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-kappaB signaling pathway in HepG2 cells. Arterioscler Thromb Vasc Biol. 2017;37(6):1241\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"316_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52(2):192\u2013203.","journal-title":"Exp Mol Med"},{"issue":"2","key":"316_CR51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1099800417747411","volume":"20","author":"DE Lyon","year":"2018","unstructured":"Lyon DE, Starkweather A, Yao Y, Garrett T, Kelly DL, Menzies V, et al. Pilot study of metabolomics and psychoneurological symptoms in women with early stage breast cancer. Biol Res Nurs. 2018;20(2):227\u201336.","journal-title":"Biol Res Nurs"}],"container-title":["Cancer &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-023-00316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40170-023-00316-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-023-00316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T08:31:32Z","timestamp":1700382692000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerandmetabolism.biomedcentral.com\/articles\/10.1186\/s40170-023-00316-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1186\/s40170-023-00316-0","relation":{},"ISSN":["2049-3002"],"issn-type":[{"value":"2049-3002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in this study. This study was approved by the review boards of Tanzania National Institute for Medical Research, Ocean Road Cancer Institute, the University of Zambia Biomedical Research Ethics Committee, and the University of Nebraska-Lincoln (UNL) under protocol code 2261, effective 6 July 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study participants signed a written consent document after consultation with a clinical recruiter, indicating a willingness for their deidentified bio-specimens to be included in downstream research activities.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}